Training experts in understanding drug use and safety for heart, lung, and blood conditions
NHLBI Training Program in Pharmacoepidemiology
This study is all about teaching future healthcare experts how to safely and effectively use medications for heart, lung, and blood conditions, so they can help improve patient health.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10766986 on NIH RePORTER |
What this research studies
This research focuses on training pre- and post-doctoral students in pharmacoepidemiology, which combines pharmacology and epidemiology to assess the safety and effectiveness of drugs in large populations. The program aims to equip future experts with the necessary skills to analyze the benefits and risks of new therapies, particularly those targeting heart, lung, and blood conditions. By utilizing advanced tools and methodologies, the training will help improve the understanding of how these medications can be best used to enhance patient health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals with heart, lung, or blood disorders who may be affected by new therapies.
Not a fit: Patients with conditions unrelated to heart, lung, or blood disorders may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved drug safety and effectiveness for patients with heart, lung, and blood conditions.
How similar studies have performed: Previous research in pharmacoepidemiology has shown success in improving drug safety and effectiveness, indicating that this approach is both relevant and tested.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Alexander, G. Caleb — Johns Hopkins University
- Study coordinator: Alexander, G. Caleb
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.